[Thrombocytopenia due to glibenclamide].
A 45-year-old male, admitted for severe thrombocytopenia and bleeding tendency related to treatment with glibenclamide is presented. Thrombocytopenic purpura associated with glibenclamide, a short-acting sulfonylurea, is rare. We suggest that platelet counts be performed shortly after initiation of glibenclamide administration, and every 3 months thereafter.
Ganam
R
R
Dept. of Medicine A, Hillel Yaffe Medical Center, Hadera.
Zidan
F
F
Weiner
P
P
D005905:Glyburide / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced*
D005905:Glyburide